Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity
European Journal of Immunology · 2025
DOI: 10.1002/eji.70020 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Radosław Kacorzyk und 6 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Aspirin, Lymphocytes, Immunity, Innate, Asthma, Aspirin-Induced. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland (Narodowe Centrum Nauki), Narodowe Centrum Nauki, The article processing charge was funded by the "Visibility & Mobility Module" under the "Strategic Programme Excellence Initiative - Research University" at t….
Abstract (Originalsprache)
Previous studies confirmed increased group 2 innate lymphoid cell (ILC2s) count in nasal scrapings, alongside a reduced blood ILC2 count, in patients with nonsteroidal anti‐inflammatory drug‐exacerbated respiratory disease (N‐ERD) after intranasal administration of cyclooxygenase‐1 inhibitors. This study aimed to assess the role of blood and sputum ILCs in N‐ERD patients during oral aspirin‐induced bronchospasm and to compare patients with eosinophilic and noneosinophilic airway inflammatory phenotypes of asthma. Induced sputum, blood, and urine samples were collected in 24 patients with confirmed N‐ERD at baseline and during aspirin‐induced bronchospasm. Sputum and blood ILC counts were evaluated using flow cytometry. There was a significant increase in blood ILC1 count ( p < 0.001) and percentage ( p = 0.003) during aspirin‐induced bronchospasm. No significant changes in sputum ILCs were observed, but the number of detected ILCs was very low. There was a significant reduction in induced sputum supernatant (ISS) levels of prostaglandins PGE 2 ( p = 0.004) and PGD 2 ( p = 0.045), leukotriene B 4 ( p = 0.045), and 15‐oxo‐eicosatetraenoic acid ( p = 0.045) during aspirin‐induced bronchospasm. Blood ILC1 count is increased during oral aspirin‐induced bronchospasm in patients with N‐ERD, but sputum ILC count at baseline is very low. Therefore, no reliable changes in sputum ILC counts can be detected during bronchospasm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.
- Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
- Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
- Łukasiewicz Research Network - PORT Polish Center for Technology Development, Bioengineering Group, Wroclaw, Poland.
- Department of Applied Mathematics, AGH University of Science and Technology, Kraków, Poland.
ORCID-Profile: Lucyna Mastalerz
Förderung
- National Science Centre, Poland (Narodowe Centrum Nauki)
- Narodowe Centrum Nauki
- The article processing charge was funded by the "Visibility & Mobility Module" under the "Strategic Programme Excellence Initiative - Research University" at t…
Zitieren
APA
Kacorzyk, R., Jakiela, B., Maciejska, A., Węgrzyn, A. S., Ćmiel, A., Sanak, M., & Mastalerz, L. (2025). Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity. European Journal of Immunology. https://doi.org/10.1002/eji.70020
Vancouver
Kacorzyk R, Jakiela B, Maciejska A, Węgrzyn AS, Ćmiel A, Sanak M, et al. Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity. European Journal of Immunology. 2025. doi:10.1002/eji.70020
BibTeX
@article{Kacorzyk2025,
author = {Kacorzyk, Radosław and Jakiela, Bogdan and Maciejska, Alicja and Węgrzyn, Agnieszka S and Ćmiel, Adam and Sanak, Marek and Mastalerz, Lucyna},
title = {Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70020}
}
EUVIMED